Mic Iwashima
Chief Operating Officer bei SATSUMA PHARMACEUTICALS, INC.
Aktive Positionen von Mic Iwashima
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SATSUMA PHARMACEUTICALS, INC. | Chief Operating Officer | 01.01.2017 | - |
Karriereverlauf von Mic Iwashima
Ausbildung von Mic Iwashima
| North Carolina State University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 3 |
Operativ
| Chief Operating Officer | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Consumer Services | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Satsuma Pharmaceuticals, Inc.
 Satsuma Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It develops novel therapeutic products for the acute treatment of migraines. Its product candidate, STS101, is a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, or DHE, which is designed to be self-administered with a proprietary pre-filled, single-use, nasal delivery device. The company was founded by John Kollins on June 21, 2016 and is headquartered in Durham, NC. | Health Technology |
- Börse
- Insiders
- Mic Iwashima
- Erfahrung
